Company & Sponsor Intelligence

UCB Pharma

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials29

Recruiting0

Completed28

Countries7

Therapeutic footprint

epilepsyparkinsons

Indexed studies

NCT00175825A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
epilepsy · United StatesPHASE2

NCT00151879Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures
epilepsy · United StatesPHASE2, PHASE3

NCT00245713Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.
epilepsy · PHASE4

NCT00955357Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures
epilepsy · United StatesPHASE4

NCT00761774An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam
epilepsy · United StatesPHASE3

NCT00522379Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch
parkinsons · United StatesPHASE3

NCT00139867A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease
parkinsons · United StatesPHASE3

NCT01210690Observational Study in Infants Who Are Prescribed Treatment With Keppra® (Levetiracetam) Oral Solution
epilepsy · FranceCOMPLETED

NCT00535392Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
epilepsy · United StatesPHASE2

NCT00630357Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy
epilepsy · PHASE4

NCT01504529Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
parkinsons · SpainCOMPLETED

NCT00150787Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.
epilepsy · PHASE3

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →